Molecular pathogenesis of diffuse large B-cell lymphoma

G Saglio; M Bosa; M Gino; S Ulisciani; G Parvis

doi:10.4081/hmr.v2i7.419

Abstracts

8 June 2009

Vol. 2 No. 7 (2006)

https://doi.org/10.4081/hmr.v2i7.419

Molecular pathogenesis of diffuse large B-cell lymphoma

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

PDF

213

Views

1076

Downloads

Authors

G Saglio

support@pagepress.org

M Bosa

M Gino

S Ulisciani

G Parvis

Diffuse Large B-Cell Lymphomas (DLBCLs) are the most common histologic subtype within non-Hodgkin’s lymphomas (NHLs), accounting for approximately 30% of them. These lymphomas are a heterogeneous clinicopathologic entity characterized by marked phenotypic and clinical differences and several data indeed suggest that under the name of DLBCL different disease entities are currently included. This vision is supported by the fact that DLBCL subtypes are characterized by different cells of origin and by different cytogenetic and molecular aberrations and, therefore, by a distinct pathogenesis.